KRTAP5-5
gene geneOn this page
Also known as KRTAP5.5KRTAP5-11
Summary
KRTAP5-5 (keratin associated protein 5-5, HGNC:23601) is a protein-coding gene on chromosome 11p15.5, encoding Keratin-associated protein 5-5 (Q701N2). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated protein (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linki….
Predicted to act upstream of or within hematopoietic progenitor cell differentiation. Predicted to be located in cytosol.
Source: NCBI Gene 439915 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 42 total
- MANE Select transcript:
NM_001001480
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23601 |
| Approved symbol | KRTAP5-5 |
| Name | keratin associated protein 5-5 |
| Location | 11p15.5 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KRTAP5.5, KRTAP5-11 |
| Ensembl gene | ENSG00000185940 |
| Ensembl biotype | protein_coding |
| Entrez | 439915 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000399676
RefSeq mRNA: 1 — MANE Select: NM_001001480
NM_001001480
CCDS: CCDS41592
Canonical transcript exons
ENST00000399676 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001539583 | 1629775 | 1630930 |
Expression profiles
Bgee: expression breadth broad, 33 present calls, max score 94.70.
Top tissues by expression
123 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| thymus | UBERON:0002370 | 94.70 | gold quality |
| quadriceps femoris | UBERON:0001377 | 76.61 | gold quality |
| cerebellar vermis | UBERON:0004720 | 68.53 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 53.21 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 50.57 | gold quality |
| cerebellum | UBERON:0002037 | 50.35 | gold quality |
| cerebellar cortex | UBERON:0002129 | 50.27 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 49.83 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 44.41 | silver quality |
| gall bladder | UBERON:0002110 | 40.99 | gold quality |
| ventricular zone | UBERON:0003053 | 40.61 | silver quality |
| skin of abdomen | UBERON:0001416 | 40.18 | gold quality |
| zone of skin | UBERON:0000014 | 39.95 | gold quality |
| skin of leg | UBERON:0001511 | 39.95 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| sural nerve | UBERON:0015488 | 36.37 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 36.26 | silver quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| transverse colon | UBERON:0001157 | 34.67 | gold quality |
| duodenum | UBERON:0002114 | 34.62 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 34.55 | silver quality |
| islet of Langerhans | UBERON:0000006 | 34.21 | gold quality |
| small intestine | UBERON:0002108 | 32.65 | gold quality |
| bone marrow | UBERON:0002371 | 32.54 | silver quality |
| muscle tissue | UBERON:0002385 | 31.95 | silver quality |
| small intestine Peyer’s patch | UBERON:0003454 | 31.95 | gold quality |
| fundus of stomach | UBERON:0001160 | 31.87 | silver quality |
| pituitary gland | UBERON:0000007 | 31.57 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
16 targeting KRTAP5-5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-218-5P | 99.93 | 72.22 | 2103 |
| HSA-MIR-3663-3P | 99.84 | 70.39 | 798 |
| HSA-MIR-4516 | 99.61 | 67.78 | 3390 |
| HSA-MIR-1252-3P | 99.55 | 67.71 | 2862 |
| HSA-MIR-6081 | 99.48 | 66.07 | 1446 |
| HSA-MIR-4786-3P | 99.36 | 68.35 | 1390 |
| HSA-MIR-6510-5P | 99.14 | 66.59 | 1081 |
| HSA-MIR-4768-3P | 98.16 | 66.02 | 2330 |
| HSA-MIR-4433A-3P | 97.75 | 62.82 | 1435 |
| HSA-MIR-3936 | 97.64 | 64.47 | 732 |
| HSA-MIR-575 | 97.54 | 65.18 | 718 |
| HSA-MIR-6806-5P | 96.37 | 68.74 | 587 |
| HSA-MIR-12115 | 94.19 | 66.37 | 738 |
Literature-anchored findings (GeneRIF, showing 1)
- KRTAP5-5 expression is significantly downregulated in human masticatory mucosa during wound healing (PMID:28005267)
Cross-species orthologs
0 orthologs
Paralogs (47): KRTAP4-4 (ENSG00000171396), KRTAP9-7 (ENSG00000180386), KRTAP12-1 (ENSG00000187175), KRTAP9-8 (ENSG00000187272), KRTAP10-8 (ENSG00000187766), KRTAP10-6 (ENSG00000188155), KRTAP1-1 (ENSG00000188581), KRTAP10-12 (ENSG00000189169), KRTAP4-3 (ENSG00000196156), KRTAP9-9 (ENSG00000198083), KRTAP4-6 (ENSG00000198090), KRTAP4-5 (ENSG00000198271), KRTAP4-1 (ENSG00000198443), KRTAP9-3 (ENSG00000204873), KRTAP4-8 (ENSG00000204880), KRTAP1-4 (ENSG00000204887), KRTAP12-3 (ENSG00000205439), KRTAP10-2 (ENSG00000205445), KRTAP5-6 (ENSG00000205864), KRTAP5-2 (ENSG00000205867), KRTAP16-1 (ENSG00000212657), KRTAP9-6 (ENSG00000212659), KRTAP4-11 (ENSG00000212721), KRTAP4-9 (ENSG00000212722), KRTAP2-3 (ENSG00000212724), KRTAP2-1 (ENSG00000212725), KRTAP10-3 (ENSG00000212935), KRTAP4-12 (ENSG00000213416), KRTAP2-4 (ENSG00000213417), KRTAP2-2 (ENSG00000214518), KRTAP10-4 (ENSG00000215454), KRTAP10-1 (ENSG00000215455), KRTAP10-9 (ENSG00000221837), KRTAP1-5 (ENSG00000221852), KRTAP10-10 (ENSG00000221859), KRTAP12-2 (ENSG00000221864), KRTAP1-3 (ENSG00000221880), KRTAP9-2 (ENSG00000239886), KRTAP9-1 (ENSG00000240542), KRTAP4-7 (ENSG00000240871)
Protein
Protein identifiers
Keratin-associated protein 5-5 — Q701N2 (reviewed: Q701N2)
Alternative names: Keratin-associated protein 5-11, Keratin-associated protein 5.11, Keratin-associated protein 5.5, Ultrahigh sulfur keratin-associated protein 5.5
All UniProt accessions (1): Q701N2
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated protein (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Tissue specificity. Restricted to hair root, not detected in any other tissues.
Similarity. Belongs to the KRTAP type 5 family.
RefSeq proteins (1): NP_001001480* (*=MANE)
Domains & families (InterPro)
UniProt features (17 total): repeat 8, sequence conflict 7, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q701N2-F1 | 42.11 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 20 (showing top):
chr11q13, HFH1_01, NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, ZWANG_EGF_INTERVAL_UP, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, ZNF2_TARGET_GENES, ZNF30_TARGET_GENES, MIR153_5P, MIR218_5P, MIR4768_3P
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (2): cytosol (GO:0005829), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
322 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP5-5 | KRTAP5-7 | Q6L8G8 | 665 |
| KRTAP5-5 | KRTAP5-1 | Q6L8H4 | 571 |
| KRTAP5-5 | OR2G3 | Q8NGZ4 | 544 |
| KRTAP5-5 | KRTAP19-8 | Q3LI54 | 506 |
| KRTAP5-5 | KRTAP6-1 | Q3LI64 | 505 |
| KRTAP5-5 | OR1N1 | Q8NGS0 | 480 |
| KRTAP5-5 | A0A3B3IRQ3 | A0A3B3IRQ3 | 480 |
| KRTAP5-5 | OR2G2 | Q8NGZ5 | 479 |
| KRTAP5-5 | A8MUN0 | A8MUN0 | 447 |
| KRTAP5-5 | OR14A16 | Q8NHC5 | 447 |
| KRTAP5-5 | OR56A3 | Q8NH54 | 446 |
| KRTAP5-5 | OR8B12 | Q8NGG6 | 432 |
| KRTAP5-5 | OR5M10 | Q6IEU7 | 432 |
| KRTAP5-5 | KRTAP22-1 | Q3MIV0 | 418 |
| KRTAP5-5 | OR11L1 | Q8NGX0 | 418 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A286YEV6, A0A286YEX9, A0A286YEY9, A0A286YF01, A0A286YF46, A0A286YF60, A0A286YF77, A0A286YFB4, A0A286YFG1, O08884, O14633, P04459, P05687, P05688, P08131, P08175, P0DSO2, P20730, P23490, Q01642, Q01643, Q01644, Q01645, Q07627, Q3LI58, Q3LI59, Q3V2C1, Q5T754, Q5TA78, Q5TA79, Q5TA81, Q5TA82, Q5TCM9, Q701N2, Q8IUG1, Q925H4, Q9BQ66, Q9BYP8, Q9BYQ5, Q9BYQ6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
42 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 30 |
| Likely benign | 11 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
972 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:71601415:C:CA | donor_gain | 0.9900 |
| 11:71602180:T:TA | donor_gain | 0.9900 |
| 11:71602181:C:A | donor_gain | 0.9900 |
| 11:71601467:A:AC | donor_gain | 0.9700 |
| 11:71602530:A:AC | donor_gain | 0.9700 |
| 11:71582643:C:CA | donor_gain | 0.9600 |
| 11:1630100:G:GT | donor_gain | 0.9500 |
| 11:71601446:T:TA | donor_gain | 0.9300 |
| 11:71582670:G:C | donor_gain | 0.9200 |
| 11:1630151:TGTCC:T | donor_gain | 0.9100 |
| 11:71582377:CA:C | donor_gain | 0.9100 |
| 11:71602576:T:TA | donor_gain | 0.9100 |
| 11:1630133:GC:G | donor_gain | 0.9000 |
| 11:71582639:AGCCC:A | donor_gain | 0.9000 |
| 11:71595173:C:G | acceptor_gain | 0.8900 |
| 11:71582814:T:TA | donor_gain | 0.8800 |
| 11:71582811:G:GA | donor_gain | 0.8700 |
| 11:71602561:C:CA | donor_gain | 0.8700 |
| 11:1629929:G:GT | donor_gain | 0.8500 |
| 11:1630010:G:T | donor_gain | 0.8400 |
| 11:71589795:CAAAG:C | acceptor_gain | 0.8400 |
| 11:1630159:G:GT | donor_gain | 0.8200 |
| 11:71589799:G:GC | acceptor_gain | 0.8200 |
| 11:71599374:G:GC | acceptor_gain | 0.8200 |
| 11:71602107:C:A | donor_gain | 0.8100 |
| 11:1629863:G:GT | donor_gain | 0.8000 |
| 11:1630089:C:G | donor_gain | 0.8000 |
| 11:71601394:A:AC | donor_gain | 0.7900 |
| 11:71602177:ACATC:A | donor_gain | 0.7900 |
| 11:71602178:CATCC:C | donor_gain | 0.7900 |
AlphaMissense
1519 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:1630050:G:C | K70N | 0.693 |
| 11:1630050:G:T | K70N | 0.693 |
| 11:1630516:A:C | S226R | 0.692 |
| 11:1630518:C:A | S226R | 0.692 |
| 11:1630518:C:G | S226R | 0.692 |
| 11:1630399:A:C | S187R | 0.672 |
| 11:1630401:C:A | S187R | 0.672 |
| 11:1630401:C:G | S187R | 0.672 |
| 11:1630548:G:C | K236N | 0.653 |
| 11:1630548:G:T | K236N | 0.653 |
| 11:1630369:A:C | S177R | 0.652 |
| 11:1630371:C:A | S177R | 0.652 |
| 11:1630371:C:G | S177R | 0.652 |
| 11:1630218:G:C | K126N | 0.612 |
| 11:1630218:G:T | K126N | 0.612 |
| 11:1630312:A:C | S158R | 0.610 |
| 11:1630314:C:A | S158R | 0.610 |
| 11:1630314:C:G | S158R | 0.610 |
| 11:1630429:A:C | S197R | 0.606 |
| 11:1630431:C:A | S197R | 0.606 |
| 11:1630431:C:G | S197R | 0.606 |
| 11:1630248:G:C | K136N | 0.602 |
| 11:1630248:G:T | K136N | 0.602 |
| 11:1630188:G:C | K116N | 0.587 |
| 11:1630188:G:T | K116N | 0.587 |
| 11:1630550:T:G | I237S | 0.585 |
| 11:1630550:T:C | I237T | 0.583 |
| 11:1630323:G:C | K161N | 0.569 |
| 11:1630323:G:T | K161N | 0.569 |
dbSNP variants (sampled 300 via entrez): RS1000436437 (11:1629746 A>G), RS1001598127 (11:1629245 A>G), RS1001872812 (11:1630869 G>A,T), RS1001938096 (11:1629465 A>G), RS1002520378 (11:1628422 G>A), RS1003006206 (11:1628257 C>T), RS1003138369 (11:1628626 C>G), RS1004058096 (11:1627915 G>A), RS1004738737 (11:1628362 G>A,T), RS1006220835 (11:1631421 C>A,T), RS1008183753 (11:1628714 G>T), RS1008395655 (11:1628258 G>A,C), RS1010293995 (11:1629681 T>A,C,G), RS1010320855 (11:1627539 CT>C), RS1011302019 (11:1628591 G>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | decreases expression, affects cotreatment | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Endosulfan | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.